NRP1 and breast carcinoma: Peptides targeting NRP-1 have been shown to induce apoptosis in human and murine breast cancer cells as well as endothelial cells, while a peptide targeting VEGFR2 only inhibited the growth of endothelial cells and did not affect the viability of breast cancer cells [18].